Form 4: Ironwood Pharmaceuticals Executive Acquires and Disposes of Class A Common Stock
SEC Form 4 Filing
Ronald Silver, Principal Accounting Officer at Ironwood Pharmaceuticals, reports changes in beneficial ownership of Class A Common Stock, including acquisition and disposal of shares.
Summary
- Ronald Silver, the Principal Accounting Officer of Ironwood Pharmaceuticals, filed a Form 4 detailing changes in his beneficial ownership of the company's Class A Common Stock.
- On January 27, 2025, Silver acquired 133,333 shares of Class A Common Stock at $0 per share.
- On the same day, Silver disposed of shares.
- Following these transactions, Silver directly owns 291,703 shares of Class A Common Stock.
- The acquisition was related to a restricted stock unit award that vests in four equal annual installments.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be an indicator of management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as an indicator of management's view of the company's value.
Key Dates
| Date | Description |
|---|---|
| 01/27/2025 | Date of transaction: acquisition and disposal of Class A Common Stock. |
| 01/29/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.